Skip to main content

Small Pharma Inc(DMT-X)
TSX Venture

Today's Change
Real-Time Last Update
Volume
Day Low0.070
Day High0.075
Open:0.075
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDFRefinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDFStockCalc

Press & news

Latest News

More Stories
Stocks in play: Small Pharma Inc.
Baystreet - Wed Jan 25, 8:47AM CST
Baystreet
Wed Jan 25, 8:47AM CST
Announces that SPL026, intravenous N,N-Dimethyltryptamine, with supportive therapy for the treatment ...
Canadian Patent Grant Strengthens Small Pharma’s International Position
Globe Newswire - Wed Aug 3, 2022
Globe Newswire
Wed Aug 3, 2022
Further Composition of Matter protection for SPL028, the Company’s next candidate expected to enter the clinic...
U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation
Globe Newswire - Tue Jul 26, 2022
Globe Newswire
Tue Jul 26, 2022
Key U.S. patent protection on injectable delivery of DMT in lead programs SPL026 and SPL028 LONDON, July 26, 2022 (GLOBE NEWSWIRE) -- Small Pharma...

Latest Articles

Tuesday’s analyst upgrades and downgrades
Thursday’s analyst upgrades and downgrades

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.